Investment Banking since 1992
EC M&A is a longstanding, trusted M&A adviser specialising in industrial and life science technologies. We assist global corporates, prominent mid-sized companies, leading private equity firms and some of the most innovative niche companies in our specialised sectors by providing unbiased advice in situations that are pivotal in the corporate life cycle.
With highly skilled professionals in New York, Chicago, Los Angeles, São Paulo, London, Frankfurt, Paris, Zurich, Prague, Milan, Hong Kong and Beijing, we help clients facilitate transactions globally.
Key Figures
Years in Service
Offices Worldwide
Completed M&A Transactions
Aggregate Deal Value ($)
%
M&A Deals are Cross-Border
%
Sell-side M&A Deals Sold to Strategic Buyers
%
Buy-side M&A Deals are Proprietary
Our Services
Investment Banking and Financial Advisory
We help you grow through acquisitions or mergers. Leveraging our network to connect you with investment partners to provide for example, growth capital, market guidance, commercial partnership, and strategic insights. We help you realign your business or portfolio of businesses to better suit your corporate objectives.
Mergers & Acquisitions
For over 30 years EC M&A has advised firms across US, Europe and Asia on mergers, acquisitions and divestitures. Most corporate events have life changing consequences for those involved. We are proud of an enviable reputation for achieving and very often exceeding our client’s objectives.
Proactive buyside, growth through acquisitions
Buyside M&A is unpredictable and difficult. Having originally built our business providing buyside services to some of the largest multi-nationals we have honed our skills and processes to provide a unique tailored buyside offering. 90% of the companies we buy for our clients are non-auction bilateral transactions; enabling our clients to acquire high quality assets at reasonable prices.
Cross-Border Transactions
Over 70% of our transactions involve the seller in one country and the buyer in another. Having worked for multi-nationals since 1992, we have an unrivalled global network of strategic buyers. By having our own people in three continents we shrink the globe for our clients seeking buyers or targets abroad.
Corporate Divestitures, and sale of non-core assets
Divestitures have their own complications. We have completed over 50 divestitures in the last 20 years providing us with the experience to ensure yours is completed smoothly.
Capital Raises
Strategic funding solutions take shape in many forms. By leveraging our market knowledge, our network of both strategic investors, their venture arms, Private Equity, and Family office investors, we can access appropriate funding for most client requirements. We work with you to assess the most suitable development of your capital and debt structure, taking into consideration your needs now and in the future, and formulate a customized approach to achieve the best possible outcome for our clients and support them in their strategic goals.
Sector Expertise
We are a leader in advising industrial technology and life science clients. Our markets include:
Industrial Technologies:
- Test & Measurement / Instruments
- Gas Analysis, Detection, Monitoring
- Industry 4.0 / IIoT
- Water/Wastewater & Environmental
- Pumps, Valves & Flow control
- Non Destructive Testing / Metrology
- Optics & Photonics
- PPE, Workwear, Safety & Security
- General Industrial Products
- Energy (Oil & Gas and Power)
- Transportation & Aerospace
- Specialty Chemicals and Ingredients
Life Sciences and Medical Technologies:
- Analytical Instruments
- Bioprocessing Technologies
- Life Science Research Tools
- Medical Devices
- Pharmaceutical Production
Recent Transactions
Carco has acquired ROW
Manufacturer of highly engineered O-Rings and gaskets used in multiple industries
LumaCyte Closes Strategic Series B Financing
Developer and manufacturer of novel bioanalytical technology
SERMA Group has acquired Microtech Laboratories
electronics and semiconductor failure analysis laboratory
